DaVita Healthcare Partners will acquire Renal Ventures Limited for $415 million.
The deal will include a 100% interest in all dialysis centers owned by Lakewood, Colo.-based Renal Ventures, which operates 36 dialysis clinics in six states.
Denver-based DaVita, which runs 2,210 clinics in 46 states, operates a large multispecialty medical group in addition to its core dialysis business.
"Our commitment is and will always be about enhancing the quality of life for our patients. We look forward to serving Renal Ventures' patients with industry-leading outcomes and comprehensive care," Javier Rodriguez, CEO of DaVita Kidney Care, said in a news release.
In its last quarterly results, DaVita continued to see higher patient volume in its kidney care division, a unit that has bolstered the company's overall financial performance in recent quarters.
Its multispecialty medical group continued to post lower year-over-year profits compared with DaVita's legacy kidney care business.
Denver-based DaVita reported second-quarter net income of $170 million after adjusting for special items, on $3.4 billion in revenue compared with net income of $148 million on $3.2 billion in revenue during the prior-year period.
The special items included $29 million in debt redemption charges and a $7.5 million tax adjustment related to its settlement of a whistle-blower suit. The whistle-blower, Dr. Alon Vainer, alleged that DaVita overbilled Medicare and Medicaid by charging the full amount for drugs that were only partially used and then discarded.
DaVita included the $495 million settlement in its first-quarter results.
